Category Archives: Ebola

Evidence Shows Ring Vaccination Strategy Effective In Limiting Ebola Outbreak In DRC

Sources: Health Policy Watch 16th April, 2019   A preliminary analysis of the World Health Organization’s “ring vaccination” strategy against Ebola shows that vaccinating people who came into contact with Ebola patients is proving to be effective at preventing new … Continue reading

Posted in Ebola, Innovation, Vaccines, WHO | Leave a comment

WHO Calls For International Support After Ebola Infections Rise In DRC

Source: Health Policy Watch 15th April, 2019 The World Health Organization called on the international community to ramp up contributions to the US$ 148 million in funding required for the next six months’ Ebola outbreak response in the Democratic Republic … Continue reading

Posted in Ebola, Neglected Diseases, WHO | Leave a comment

Universal standards of care to Ebola virus disease

Source: Science Daily 12th April, 2019 Medical researchers are calling for universal standards of care to be applied in relation to Ebola virus disease. LSTM’s Senior Clinical Lecturer, Dr Shevin Jacob is corresponding author on a perspective piece published in … Continue reading

Posted in Ebola | Leave a comment

Access to Medicines Ireland seeks change in R&D approach of pharmaceutical companies

Source: Irish Times 10th April, 2019 Drug costs threaten to bankrupt healthcare, says lobby group Access to Medicines Ireland seeks change in R&D approach of pharmaceutical companies Liberian nurses carry the body of an Ebola victim in 2014. Vaccines were … Continue reading

Posted in Access to Medicins, Drug prices, Ebola, R&D | Leave a comment

G-Finder Report: Ebola Distracted R&D Funding For Neglected Diseases; Public Funding At Low

IP Watch; December 8, 2015. A newly issued report provides the “first ever” picture of global investment in Ebola research and development. The report found that investment in Ebola might have come at the expense of other funding to develop drugs, … Continue reading

Posted in Ebola, Innovation, Neglected Diseases, Public research | Leave a comment